Skip to the page

Data / Form D filings / RevOpsis Therapeutics, Inc.

RevOpsis Therapeutics, Inc.: Form D filings

RevOpsis Therapeutics, Inc., a biotechnology company in Springfield, IL, filed 4 Form D notices with the SEC between 2022 and 2024. The latest, on November 7, 2024, reports $575,000 sold of an offering with no set size to 4 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
4109 CHANDLERWOOD, Springfield, IL, 62711
Phone
(646) 221-5178
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1939796

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 7, 2024New noticeIndefinite$575,0004Oct 24, 2024sec.gov
Aug 10, 2023New notice$7,895,004$7,895,00436Jul 26, 2023sec.gov
Aug 24, 2022New notice$18,000,000$100,000$17,900,0001Aug 19, 2022sec.gov
Jul 29, 2022New notice$521,000$0$521,0004Mar 22, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Ramanath BhandariExecutive Officer
Ram PalankiDirector

Other biotechnology companies in Illinois that filed recently

Every Form D from the week of Nov 4, 2024 · All recent filings in Illinois · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what RevOpsis Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.